BioSig Technologies, Inc. announced that it has entered into a Securities Purchase Agreement with certain accredited investors , pursuant to which the Company sold to the Investors an aggregate of 783,406 shares of the Company?s common stock, par value $0.001 per share at a purchase price of $1.4605 per share and warrants to purchase up to 391,703 shares of Common Stock at an exercise price of $1.398 per share for the aggregate gross proceeds of $1,144,164.46 on May 1, 2024. The warrants will become exercisable six months after the date of issuance and will expire five and one-half years following the date of issuance. The Securities were offered and sold in reliance on the exemption from registration under the Securities Act of 1933, as amended provided by Section 4(a)(2) of and Regulation D under the Securities Act.